Harout Semerjian's most recent trade in Geron Corp. was a trade of 7,000,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Geron Corp. | Harout Semerjian | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 7,000,000 | 7,000,000 | - | - | Stock Option (right to buy) | |
| Geron Corp. | Harout Semerjian | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 4,000,000 | 4,000,000 | - | - | Stock Option (right to buy) | |
| GlycoMimetics Inc | Harout Semerjian | Director, Chief Executive Officer | 12 Jan 2024 | 695,000 | 695,000 | - | - | Employee Stock Option (right to buy) | ||
| GlycoMimetics Inc | Harout Semerjian | Director, Chief Executive Officer | 19 Jan 2023 | 651,200 | 651,200 | - | - | Employee Stock Option (right to buy) | ||
| GlycoMimetics Inc | Harout Semerjian | Director, Chief Executive Officer | 11 Nov 2022 | 25,000 | 25,000 (0%) | 0% | 1.3 | 32,250 | Common Stock | |
| GlycoMimetics Inc | Harout Semerjian | Director, Chief Executive Officer | 21 Jan 2022 | 423,500 | 423,500 | - | - | Employee Stock Option (right to buy) |